Referencias - Abbott FreeStyle Optium Neo Manual Del Usuario

Referencias

1. Schade DS, Eaton RP. Metabolic and clinical significance of ketosis. Special Topics in Endocrinology and
Metabolism 1982; 4:1–27.
2. Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Treatment of diabetic
ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency
management. Diabetes Care 1997; 20:1347–1352.
3. Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A, Uno S, Shigeta Y. Ketone bodies as markers for
Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetes control. Diabetologia 1984;
26:343-348.
4. Ubukata E. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and non-insulin-
dependent diabetes mellitus patients: The relationship to serum C-peptide immunoreactivity and free insulin.
Ann Nutr Metab 1990; 34:333–342.
5. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin therapy on
glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37:1470–1477.
6. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med
J 1984; 289; 1035–1038.
44